But if you get proper treatment promptly ... and eye trauma. With a branch retinal artery occlusion, the blood flow to the retina can become blocked due to a clot. This can damage the retina ...

If approved, Eylea would be the first treatment for RVO with 8-week dosing. The FDA target action date is Aug. 19, 2025.

If approved, EYLEA HD would introduce the first treatment for RVO with a ... including those with central retinal vein occlusion, branch retinal vein occlusion, or hemiretinal vein occlusion.

Diagnosis. Susac syndrome, characterized by a combination of encephalopathy, branch retinal artery occlusions, and hearing loss. Management. Long-term immunosuppressive treatment with azathioprine ...

Aims Previous studies have suggested an association between retinal artery occlusion (RAO) and ischaemic stroke (IS), both ...